EdgarLookup

AN2 Therapeutics, Inc. — EFFECT Filings

2 EFFECT filings on record

This page lists all EFFECT filings submitted to the SEC by AN2 Therapeutics, Inc. (ANTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. AN2 Therapeutics, Inc. has filed 2 EFFECT documents with the SEC since 2021. To view all SEC filings by AN2 Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 3/A 4 4/A 424B4 424B5 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A S-1 S-1/A S-1MEF S-3 S-8 SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
EFFECT — 9999999995-23-000930 Apr 13, 2023 —
EFFECT — 9999999995-22-000716 Mar 24, 2022 —